| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 H2BC12 | 5.36e-17 | 100 | 124 | 15 | GO:0030527 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 H2BC12 | 2.65e-08 | 398 | 124 | 15 | GO:0046982 |
| GeneOntologyMolecularFunction | structural molecule activity | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 EFEMP1 H2BC4 H2BC17 H2BC21 H2BK1 MRPS15 ERVK-18 DNM3 H2BC5 H2BC3 CROCC H2BC12 | 5.87e-07 | 891 | 124 | 20 | GO:0005198 |
| GeneOntologyMolecularFunction | activin receptor activity, type I | 2.32e-06 | 5 | 124 | 3 | GO:0016361 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 9.50e-06 | 22 | 124 | 4 | GO:0050998 | |
| GeneOntologyMolecularFunction | activin receptor activity | 1.91e-05 | 9 | 124 | 3 | GO:0017002 | |
| GeneOntologyMolecularFunction | activin binding | 4.94e-05 | 12 | 124 | 3 | GO:0048185 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO9 ATP6V1B2 SLC11A2 TCIRG1 GRID2 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCN8A TRPM8 CACNG4 CTNS | 1.20e-04 | 793 | 124 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP6V1B2 SLC11A2 TCIRG1 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCN8A TRPM8 CACNG4 CTNS | 1.44e-04 | 627 | 124 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | I-SMAD binding | 1.49e-04 | 17 | 124 | 3 | GO:0070411 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.50e-04 | 81 | 124 | 5 | GO:0035254 | |
| GeneOntologyMolecularFunction | protein dimerization activity | H2BC11 ACVR1 WDR54 CLPX H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 DNM1 H2BC12 | 1.59e-04 | 1205 | 124 | 19 | GO:0046983 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.88e-04 | 85 | 124 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.98e-04 | 86 | 124 | 5 | GO:0046332 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 2.47e-04 | 20 | 124 | 3 | GO:0004675 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO9 ATP6V1B2 SLC11A2 TCIRG1 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCN8A TRPM8 CACNG4 CTNS | 2.62e-04 | 758 | 124 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 3.43e-04 | 210 | 124 | 7 | GO:0019903 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 3.52e-04 | 54 | 124 | 4 | GO:0005246 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO9 ATP6V1B2 SLC11A2 SLC35C1 TCIRG1 GRID2 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCN8A TRPM8 CACNG4 SLC35E3 CTNS SLC44A3 | 3.59e-04 | 1180 | 124 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | ubiquitin-like protein-specific endopeptidase activity | 3.78e-04 | 5 | 124 | 2 | GO:0070137 | |
| GeneOntologyMolecularFunction | SUMO-specific endopeptidase activity | 3.78e-04 | 5 | 124 | 2 | GO:0070139 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 3.78e-04 | 5 | 124 | 2 | GO:0005025 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 4.30e-04 | 24 | 124 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | helicase activity | 4.62e-04 | 158 | 124 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | D2 dopamine receptor binding | 7.87e-04 | 7 | 124 | 2 | GO:0031749 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP6V1B2 SLC11A2 TCIRG1 ITPR1 SLC38A2 SLC9C1 CACNG8 SLC9A2 SCN8A TRPM8 CACNG4 CTNS | 8.85e-04 | 664 | 124 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | transporter activity | ANO9 ATP6V1B2 SLC11A2 SLC35C1 TCIRG1 GRID2 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCN8A TRPM8 CACNG4 SLC35E3 CTNS SLC44A3 | 1.01e-03 | 1289 | 124 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 1.15e-03 | 188 | 124 | 6 | GO:0015078 | |
| GeneOntologyMolecularFunction | phosphatase binding | 1.32e-03 | 264 | 124 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.32e-03 | 35 | 124 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 1.42e-03 | 78 | 124 | 4 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 1.56e-03 | 80 | 124 | 4 | GO:0008186 | |
| GeneOntologyMolecularFunction | chondroitin sulfate binding | 2.03e-03 | 11 | 124 | 2 | GO:0035374 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.29e-03 | 459 | 124 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC11A2 ITPR1 SLC38A2 SLC9C1 CACNG8 SLC9A2 SCN8A TRPM8 CACNG4 | 2.49e-03 | 465 | 124 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 2.52e-03 | 296 | 124 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.77e-03 | 301 | 124 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 2.85e-03 | 13 | 124 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | STAT family protein binding | 2.85e-03 | 13 | 124 | 2 | GO:0097677 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP6V1B2 SLC11A2 SLC35C1 TCIRG1 SLC38A2 SLC9C1 SLC9A2 SLC35E3 CTNS | 2.96e-03 | 477 | 124 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 3.32e-03 | 14 | 124 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 3.32e-03 | 14 | 124 | 2 | GO:0005338 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 3.43e-03 | 162 | 124 | 5 | GO:0099106 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 4.14e-03 | 52 | 124 | 3 | GO:0035255 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | LILRA3 ADGRG3 GRID2 OR2S2 ACVR1 ACVR1C TGFBR1 PTK2B EFEMP1 NRXN1 OR6C75 C3AR1 ADGRE5 ROS1 LTB4R OR51B2 ADGRD1 | 4.21e-03 | 1353 | 124 | 17 | GO:0004888 |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 4.34e-03 | 16 | 124 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | channel regulator activity | 4.64e-03 | 174 | 124 | 5 | GO:0016247 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.89e-03 | 334 | 124 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1B2 DDX52 ZGRF1 TCIRG1 CLPX HELZ2 DDX60L ASCC3 DNAH5 DHX34 | 4.98e-03 | 614 | 124 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | transporter regulator activity | 4.98e-03 | 177 | 124 | 5 | GO:0141108 | |
| GeneOntologyMolecularFunction | channel activity | 5.51e-03 | 525 | 124 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.58e-03 | 526 | 124 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 6.10e-03 | 19 | 124 | 2 | GO:0022821 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC3 | 2.85e-09 | 122 | 122 | 10 | GO:0006334 |
| GeneOntologyBiologicalProcess | nucleosome organization | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC3 | 1.24e-08 | 142 | 122 | 10 | GO:0034728 |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 2.00e-08 | 30 | 122 | 6 | GO:0002227 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SENP6 H2BC3 | 2.75e-07 | 249 | 122 | 11 | GO:0065004 |
| GeneOntologyBiologicalProcess | mucosal immune response | 3.79e-07 | 48 | 122 | 6 | GO:0002385 | |
| GeneOntologyBiologicalProcess | determination of bilateral symmetry | 6.07e-07 | 165 | 122 | 9 | GO:0009855 | |
| GeneOntologyBiologicalProcess | specification of symmetry | 6.07e-07 | 165 | 122 | 9 | GO:0009799 | |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 7.75e-07 | 54 | 122 | 6 | GO:0002251 | |
| GeneOntologyBiologicalProcess | determination of left/right symmetry | 3.77e-06 | 154 | 122 | 8 | GO:0007368 | |
| GeneOntologyBiologicalProcess | left/right pattern formation | 5.49e-06 | 162 | 122 | 8 | GO:0060972 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 1.13e-05 | 85 | 122 | 6 | GO:0019731 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 1.50e-05 | 134 | 122 | 7 | GO:0061844 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 1.51e-05 | 186 | 122 | 8 | GO:0019730 | |
| GeneOntologyBiologicalProcess | regionalization | MKKS RTTN CHSY1 ACVR1 ACVR1C ITGAM NOMO1 TGFBR1 MEGF8 PCSK6 CTNNB1 DNAH5 | 2.71e-05 | 478 | 122 | 12 | GO:0003002 |
| GeneOntologyBiologicalProcess | activin receptor signaling pathway | 2.81e-05 | 60 | 122 | 5 | GO:0032924 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 3.12e-05 | 150 | 122 | 7 | GO:0050830 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 3.22e-05 | 11 | 122 | 3 | GO:0016185 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 5.93e-05 | 36 | 122 | 4 | GO:0061037 | |
| GeneOntologyBiologicalProcess | synaptic vesicle localization | 6.35e-05 | 71 | 122 | 5 | GO:0097479 | |
| GeneOntologyBiologicalProcess | pattern specification process | MKKS RTTN CHSY1 ACVR1 ACVR1C ITGAM NOMO1 TGFBR1 MEGF8 PCSK6 CTNNB1 DNAH5 | 6.81e-05 | 526 | 122 | 12 | GO:0007389 |
| GeneOntologyBiologicalProcess | synaptic vesicle budding | 8.72e-05 | 15 | 122 | 3 | GO:0070142 | |
| GeneOntologyBiologicalProcess | centriole-centriole cohesion | 8.72e-05 | 15 | 122 | 3 | GO:0010457 | |
| GeneOntologyBiologicalProcess | positive regulation of determination of dorsal identity | 1.04e-04 | 3 | 122 | 2 | GO:2000017 | |
| GeneOntologyBiologicalProcess | vesicle scission | 1.04e-04 | 3 | 122 | 2 | GO:0099050 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 1.20e-04 | 43 | 122 | 4 | GO:0051968 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.35e-04 | 132 | 122 | 6 | GO:0035249 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | SMURF1 ITPR1 TGFBR1 PTK2B EFEMP1 NRXN1 MEGF8 DNM3 CCL19 CROCC DNM2 | 1.71e-04 | 494 | 122 | 11 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 2.17e-04 | 92 | 122 | 5 | GO:0051966 | |
| GeneOntologyBiologicalProcess | negative regulation of activin receptor signaling pathway | 2.48e-04 | 21 | 122 | 3 | GO:0032926 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density assembly | 2.48e-04 | 21 | 122 | 3 | GO:0099151 | |
| GeneOntologyBiologicalProcess | synaptic vesicle transport | 2.93e-04 | 54 | 122 | 4 | GO:0048489 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO9 ATP6V1B2 SLC11A2 TCIRG1 GRID2 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCARA5 SCN8A TRPM8 CACNG4 CTNS CCL19 | 3.04e-04 | 1115 | 122 | 17 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO9 ATP6V1B2 SLC11A2 TCIRG1 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCARA5 SCN8A TRPM8 CACNG4 CTNS CCL19 | 3.28e-04 | 1017 | 122 | 16 | GO:0098660 |
| GeneOntologyBiologicalProcess | protein O-linked fucosylation | 3.43e-04 | 5 | 122 | 2 | GO:0036066 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP6V1B2 SLC11A2 TCIRG1 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCARA5 SCN8A TRPM8 CACNG4 CTNS CCL19 | 3.59e-04 | 922 | 122 | 15 | GO:0098662 |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 4.22e-04 | 25 | 122 | 3 | GO:2000311 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO9 ATP6V1B2 SLC11A2 TCIRG1 GRID2 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCARA5 SCN8A TRPM8 CACNG4 CTNS CCL19 CTNNB1 DNM2 | 4.47e-04 | 1374 | 122 | 19 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP6V1B2 SLC11A2 TCIRG1 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCARA5 SCN8A TRPM8 CACNG4 CTNS CCL19 | 4.50e-04 | 942 | 122 | 15 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP6V1B2 SLC11A2 TCIRG1 ITPR1 SLC38A2 PTK2B SLC9C1 CACNG8 SLC9A2 SCARA5 SCN8A TRPM8 CACNG4 CTNS CCL19 CTNNB1 DNM2 | 4.65e-04 | 1157 | 122 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic specialization assembly | 4.75e-04 | 26 | 122 | 3 | GO:0099150 | |
| GeneOntologyBiologicalProcess | regulation of excitatory synapse assembly | 4.75e-04 | 26 | 122 | 3 | GO:1904889 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | SMURF1 MCF2 RTN4RL1 GRID2 ITPR1 TGFBR1 PTK2B EFEMP1 NRXN1 MEGF8 DNM3 CCL19 CROCC DNM2 | 4.82e-04 | 846 | 122 | 14 | GO:0120035 |
| GeneOntologyBiologicalProcess | ciliary basal body organization | 5.12e-04 | 6 | 122 | 2 | GO:0032053 | |
| GeneOntologyBiologicalProcess | regulation of determination of dorsal identity | 5.12e-04 | 6 | 122 | 2 | GO:2000015 | |
| GeneOntologyBiologicalProcess | proton transmembrane transport | 5.27e-04 | 170 | 122 | 6 | GO:1902600 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 5.32e-04 | 27 | 122 | 3 | GO:1905874 | |
| GeneOntologyBiologicalProcess | negative regulation of chondrocyte differentiation | 5.32e-04 | 27 | 122 | 3 | GO:0032331 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | SMURF1 MCF2 RTN4RL1 GRID2 ITPR1 TGFBR1 PTK2B EFEMP1 NRXN1 MEGF8 DNM3 CCL19 CROCC DNM2 | 5.87e-04 | 863 | 122 | 14 | GO:0031344 |
| GeneOntologyBiologicalProcess | humoral immune response | 6.54e-04 | 321 | 122 | 8 | GO:0006959 | |
| GeneOntologyBiologicalProcess | vesicle localization | 6.76e-04 | 247 | 122 | 7 | GO:0051648 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 6.76e-04 | 247 | 122 | 7 | GO:0009612 | |
| GeneOntologyBiologicalProcess | receptor internalization | 7.54e-04 | 182 | 122 | 6 | GO:0031623 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 8.26e-04 | 123 | 122 | 5 | GO:0120034 | |
| GeneOntologyBiologicalProcess | regulation of activin receptor signaling pathway | 8.83e-04 | 32 | 122 | 3 | GO:0032925 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 8.96e-04 | 337 | 122 | 8 | GO:0006898 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport, postsynaptic endosome to lysosome | 9.49e-04 | 8 | 122 | 2 | GO:0098943 | |
| GeneOntologyCellularComponent | nucleosome | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 H2BC12 | 5.01e-15 | 138 | 126 | 15 | GO:0000786 |
| GeneOntologyCellularComponent | activin receptor complex | 4.22e-06 | 6 | 126 | 3 | GO:0048179 | |
| GeneOntologyCellularComponent | secretory granule membrane | LILRA3 ADGRG3 UBR4 TCIRG1 DCST2 ITGAM ITGAX ITPR1 C3AR1 ADGRE5 | 3.12e-05 | 329 | 126 | 10 | GO:0030667 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.55e-04 | 45 | 126 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | specific granule membrane | 2.26e-04 | 91 | 126 | 5 | GO:0035579 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.34e-04 | 50 | 126 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 2.76e-04 | 350 | 126 | 9 | GO:0098802 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 5.04e-04 | 61 | 126 | 4 | GO:0101003 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ATP6V1B2 LILRA3 ADGRG3 SLC11A2 UBR4 TCIRG1 DCST2 ITGAM ITGAX ITPR1 CACNG8 SCARA5 C3AR1 ADGRE5 CACNG4 CTNS ARHGAP21 DNM2 | 8.48e-04 | 1307 | 126 | 18 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ATP6V1B2 LILRA3 ADGRG3 SLC11A2 UBR4 TCIRG1 DCST2 ITGAM ITGAX ITPR1 CACNG8 SCARA5 C3AR1 ADGRE5 CACNG4 CTNS ARHGAP21 DNM2 | 9.92e-04 | 1325 | 126 | 18 | GO:0012506 |
| GeneOntologyCellularComponent | tertiary granule membrane | 9.93e-04 | 73 | 126 | 4 | GO:0070821 | |
| GeneOntologyCellularComponent | cell surface | SLC11A2 MUC16 RTN4RL1 ACVR1C ITGAM ITGAX TGFBR1 H2BC1 NRXN1 SCARA5 PCSK6 TRPM8 ADGRE5 ROS1 CACNG4 CCL19 | 1.06e-03 | 1111 | 126 | 16 | GO:0009986 |
| GeneOntologyCellularComponent | photoreceptor inner segment | 1.27e-03 | 78 | 126 | 4 | GO:0001917 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | GRID2 ITPR1 PTK2B CACNG8 NRXN1 SCN8A DNM3 CACNG4 CTNNB1 DNM2 | 1.27e-03 | 523 | 126 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | 1.67e-03 | 451 | 126 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 2.29e-03 | 12 | 126 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | endocytic vesicle | 2.31e-03 | 384 | 126 | 8 | GO:0030139 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.43e-03 | 477 | 126 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.50e-03 | 155 | 126 | 5 | GO:0098685 | |
| GeneOntologyCellularComponent | receptor complex | GRID2 ACVR1 ACVR1C ITGAM ITGAX TGFBR1 PTK2B CACNG8 ROS1 CACNG4 | 2.75e-03 | 581 | 126 | 10 | GO:0043235 |
| GeneOntologyCellularComponent | synaptic membrane | 2.82e-03 | 583 | 126 | 10 | GO:0097060 | |
| GeneOntologyCellularComponent | specific granule | 2.87e-03 | 160 | 126 | 5 | GO:0042581 | |
| GeneOntologyCellularComponent | tertiary granule | 3.19e-03 | 164 | 126 | 5 | GO:0070820 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 3.22e-03 | 49 | 126 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | chromatin | H2BC11 XPC H2BC18 H2BC12L KANSL3 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 CTNNB1 H2BC12 | 3.35e-03 | 1480 | 126 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | postsynaptic specialization | 3.46e-03 | 503 | 126 | 9 | GO:0099572 | |
| HumanPheno | Abnormality of the dentition | MKKS ATP6V1B2 FAT4 PIGK SLC35C1 CHSY1 TCIRG1 XPC ACVR1 IDUA B3GAT3 ITPR1 EFEMP1 PNPLA6 MEGF8 SCN8A TMEM270 ASCC3 DNM1 | 1.39e-05 | 1030 | 36 | 19 | HP:0000164 |
| Domain | H2B | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.44e-24 | 21 | 123 | 13 | SM00427 |
| Domain | HISTONE_H2B | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.44e-24 | 21 | 123 | 13 | PS00357 |
| Domain | Histone_H2B | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.44e-24 | 21 | 123 | 13 | IPR000558 |
| Domain | Histone | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.41e-17 | 56 | 123 | 13 | PF00125 |
| Domain | Histone_H2A/H2B/H3 | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.41e-17 | 56 | 123 | 13 | IPR007125 |
| Domain | Histone-fold | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.22e-15 | 83 | 123 | 13 | IPR009072 |
| Domain | - | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.47e-14 | 69 | 123 | 12 | 1.10.20.10 |
| Domain | Dynamin_central | 5.49e-06 | 6 | 123 | 3 | IPR000375 | |
| Domain | GED | 5.49e-06 | 6 | 123 | 3 | SM00302 | |
| Domain | GED | 5.49e-06 | 6 | 123 | 3 | PS51388 | |
| Domain | Dynamin_M | 5.49e-06 | 6 | 123 | 3 | PF01031 | |
| Domain | Dynamin_GTPase_CS | 5.49e-06 | 6 | 123 | 3 | IPR019762 | |
| Domain | GED_dom | 5.49e-06 | 6 | 123 | 3 | IPR020850 | |
| Domain | GED | 5.49e-06 | 6 | 123 | 3 | PF02212 | |
| Domain | GED | 5.49e-06 | 6 | 123 | 3 | IPR003130 | |
| Domain | GS | 9.57e-06 | 7 | 123 | 3 | SM00467 | |
| Domain | G_DYNAMIN_1 | 9.57e-06 | 7 | 123 | 3 | PS00410 | |
| Domain | GS_dom | 9.57e-06 | 7 | 123 | 3 | IPR003605 | |
| Domain | GS | 9.57e-06 | 7 | 123 | 3 | PS51256 | |
| Domain | TGF_beta_GS | 9.57e-06 | 7 | 123 | 3 | PF08515 | |
| Domain | DYNc | 9.57e-06 | 7 | 123 | 3 | SM00053 | |
| Domain | Activin_recp | 3.23e-05 | 10 | 123 | 3 | IPR000472 | |
| Domain | Activin_recp | 3.23e-05 | 10 | 123 | 3 | PF01064 | |
| Domain | TGFB_receptor | 5.87e-05 | 12 | 123 | 3 | IPR000333 | |
| Domain | G_DYNAMIN_dom | 9.62e-05 | 14 | 123 | 3 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 9.62e-05 | 14 | 123 | 3 | PS51718 | |
| Domain | Dynamin_GTPase | 1.20e-04 | 15 | 123 | 3 | IPR001401 | |
| Domain | Dynamin_N | 1.20e-04 | 15 | 123 | 3 | PF00350 | |
| Domain | Dynamin_SF | 1.20e-04 | 15 | 123 | 3 | IPR022812 | |
| Domain | ASX_HYDROXYL | 5.22e-04 | 100 | 123 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.81e-04 | 106 | 123 | 5 | IPR000152 | |
| Domain | Peptidase_C48 | 8.84e-04 | 7 | 123 | 2 | PF02902 | |
| Domain | ULP_PROTEASE | 8.84e-04 | 7 | 123 | 2 | PS50600 | |
| Domain | Peptidase_C48_C | 8.84e-04 | 7 | 123 | 2 | IPR003653 | |
| Domain | VDCC_gsu | 1.17e-03 | 8 | 123 | 2 | IPR008368 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.37e-03 | 73 | 123 | 4 | IPR011545 | |
| Domain | DEAD | 1.37e-03 | 73 | 123 | 4 | PF00270 | |
| Domain | GPS | 1.44e-03 | 34 | 123 | 3 | SM00303 | |
| Domain | GPS | 1.56e-03 | 35 | 123 | 3 | PF01825 | |
| Domain | GPS | 1.70e-03 | 36 | 123 | 3 | PS50221 | |
| Domain | ARM-type_fold | 1.83e-03 | 339 | 123 | 8 | IPR016024 | |
| Domain | GPS | 1.84e-03 | 37 | 123 | 3 | IPR000203 | |
| Domain | Sugar_P_trans_dom | 1.87e-03 | 10 | 123 | 2 | IPR004853 | |
| Domain | TPT | 1.87e-03 | 10 | 123 | 2 | PF03151 | |
| Domain | Integrin_alpha | 2.28e-03 | 11 | 123 | 2 | PF00357 | |
| Domain | Cation/H_exchanger_CPA1 | 2.28e-03 | 11 | 123 | 2 | IPR018422 | |
| Domain | EGF_CA | 2.51e-03 | 86 | 123 | 4 | PF07645 | |
| Domain | CRAL_TRIO_2 | 2.72e-03 | 12 | 123 | 2 | PF13716 | |
| Domain | CarboxyPept_regulatory_dom | 3.20e-03 | 13 | 123 | 2 | IPR014766 | |
| Domain | - | 3.20e-03 | 13 | 123 | 2 | 2.60.40.1120 | |
| Domain | Na_H_Exchanger | 3.72e-03 | 14 | 123 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 3.72e-03 | 14 | 123 | 2 | IPR006153 | |
| Domain | Growth_fac_rcpt_ | 3.74e-03 | 156 | 123 | 5 | IPR009030 | |
| Domain | - | ATP6V1B2 DDX52 ZGRF1 CLPX HELZ2 DNM3 DDX60L ASCC3 DNM1 DNAH5 DHX34 DNM2 | 3.78e-03 | 746 | 123 | 12 | 3.40.50.300 |
| Domain | EGF_Ca-bd_CS | 3.87e-03 | 97 | 123 | 4 | IPR018097 | |
| Domain | PH | 4.11e-03 | 229 | 123 | 6 | PF00169 | |
| Domain | EGF_CA | 4.17e-03 | 99 | 123 | 4 | PS01187 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 4.36e-03 | 50 | 123 | 3 | PS00650 | |
| Domain | 7tm_2 | 4.36e-03 | 50 | 123 | 3 | PF00002 | |
| Domain | RmlC-like_jellyroll | 4.61e-03 | 51 | 123 | 3 | IPR014710 | |
| Domain | EGF | 4.66e-03 | 235 | 123 | 6 | SM00181 | |
| Domain | Integrin_alpha_C_CS | 4.86e-03 | 16 | 123 | 2 | IPR018184 | |
| Domain | CarboxyPept-like_regulatory | 5.48e-03 | 17 | 123 | 2 | IPR008969 | |
| Domain | Helicase_C | 5.49e-03 | 107 | 123 | 4 | PF00271 | |
| Domain | HELICc | 5.49e-03 | 107 | 123 | 4 | SM00490 | |
| Domain | Helicase_C | 5.67e-03 | 108 | 123 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 5.86e-03 | 109 | 123 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.86e-03 | 109 | 123 | 4 | PS51192 | |
| Domain | DEXDc | 5.86e-03 | 109 | 123 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 6.05e-03 | 110 | 123 | 4 | IPR014001 | |
| Domain | Integrin_alpha-2 | 6.14e-03 | 18 | 123 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 6.14e-03 | 18 | 123 | 2 | PF08441 | |
| Domain | Integrin_alpha | 6.14e-03 | 18 | 123 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 6.14e-03 | 18 | 123 | 2 | PS00242 | |
| Domain | EGF-like_dom | 6.15e-03 | 249 | 123 | 6 | IPR000742 | |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.66e-18 | 42 | 103 | 13 | M48029 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.72e-17 | 55 | 103 | 13 | M29526 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.79e-16 | 62 | 103 | 13 | M27700 |
| Pathway | REACTOME_DNA_METHYLATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.48e-16 | 64 | 103 | 13 | M27429 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.15e-15 | 66 | 103 | 13 | M27488 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.42e-15 | 67 | 103 | 13 | M27342 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.42e-15 | 67 | 103 | 13 | M39003 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.74e-15 | 68 | 103 | 13 | M27587 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.74e-15 | 68 | 103 | 13 | M27658 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.61e-15 | 70 | 103 | 13 | M48261 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.61e-15 | 70 | 103 | 13 | M48028 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 3.34e-15 | 91 | 103 | 14 | M27101 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.85e-15 | 72 | 103 | 13 | M29714 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.85e-15 | 72 | 103 | 13 | M27132 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.66e-15 | 73 | 103 | 13 | M27166 |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.75e-15 | 75 | 103 | 13 | M27343 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.16e-14 | 78 | 103 | 13 | M27589 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.16e-14 | 78 | 103 | 13 | M1061 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.37e-14 | 79 | 103 | 13 | M27191 |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.93e-14 | 88 | 103 | 13 | M1011 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.90e-14 | 89 | 103 | 13 | M27943 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.02e-14 | 90 | 103 | 13 | M2158 |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.02e-14 | 90 | 103 | 13 | M27691 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.02e-14 | 90 | 103 | 13 | M29668 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.24e-13 | 93 | 103 | 13 | M27487 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.43e-13 | 94 | 103 | 13 | M1080 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.43e-13 | 94 | 103 | 13 | M27230 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.90e-13 | 96 | 103 | 13 | M27792 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.18e-13 | 97 | 103 | 13 | M48262 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.18e-13 | 97 | 103 | 13 | M27590 |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 3.84e-13 | 59 | 103 | 11 | M27763 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.49e-13 | 104 | 103 | 13 | M29829 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.23e-13 | 105 | 103 | 13 | M27425 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.06e-13 | 106 | 103 | 13 | M27458 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.98e-13 | 107 | 103 | 13 | M48260 |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.02e-13 | 108 | 103 | 13 | M27426 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 H2BC18 KANSL3 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 H2BC3 | 9.09e-13 | 46 | 103 | 10 | MM14935 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.15e-12 | 110 | 103 | 13 | M27958 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.15e-12 | 110 | 103 | 13 | M27696 |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.29e-12 | 111 | 103 | 13 | M27187 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.45e-12 | 112 | 103 | 13 | M4052 |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.45e-12 | 112 | 103 | 13 | M48334 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 H2BC18 KANSL3 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.85e-12 | 142 | 103 | 14 | M27233 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.30e-12 | 116 | 103 | 13 | M29806 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.20e-12 | 119 | 103 | 13 | M607 |
| Pathway | REACTOME_MEIOSIS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.57e-12 | 120 | 103 | 13 | M529 |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.43e-12 | 122 | 103 | 13 | M29689 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.06e-12 | 125 | 103 | 13 | M27186 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.23e-12 | 128 | 103 | 13 | M48019 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.10e-12 | 129 | 103 | 13 | M27795 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 1.10e-11 | 79 | 103 | 11 | M27742 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.16e-11 | 138 | 103 | 13 | M29805 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.37e-11 | 139 | 103 | 13 | M4741 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.37e-11 | 139 | 103 | 13 | M868 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.37e-11 | 139 | 103 | 13 | M715 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.60e-11 | 140 | 103 | 13 | M27584 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.11e-11 | 142 | 103 | 13 | M48257 |
| Pathway | REACTOME_MITOTIC_PROPHASE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.11e-11 | 142 | 103 | 13 | M27660 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.73e-11 | 149 | 103 | 13 | M27888 |
| Pathway | REACTOME_REPRODUCTION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.20e-10 | 158 | 103 | 13 | M26956 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.30e-10 | 159 | 103 | 13 | M27665 |
| Pathway | REACTOME_HCMV_INFECTION | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.65e-10 | 162 | 103 | 13 | M29804 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 2.00e-10 | 55 | 103 | 9 | MM14932 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.41e-10 | 167 | 103 | 13 | M19381 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.01e-10 | 170 | 103 | 13 | M27582 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2BC11 H2BC18 TGFBR1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.21e-10 | 221 | 103 | 14 | M27578 |
| Pathway | REACTOME_DNA_REPLICATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.79e-10 | 187 | 103 | 13 | M1017 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 H2BC18 RIOX2 KANSL3 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.16e-09 | 272 | 103 | 15 | M29619 |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 1.44e-09 | 233 | 103 | 14 | M27099 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.86e-09 | 197 | 103 | 13 | M27188 |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2BC11 SMURF1 ITPR1 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 2.01e-09 | 330 | 103 | 16 | M7847 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 2.06e-09 | 31 | 103 | 7 | MM17225 | |
| Pathway | REACTOME_DNA_REPAIR | H2BC11 USP43 XPC H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ASCC3 H2BC12 | 2.20e-09 | 332 | 103 | 16 | M15434 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2BC11 H2BC12L KANSL3 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.39e-09 | 254 | 103 | 14 | M27131 |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.09e-09 | 220 | 103 | 13 | M27794 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 7.78e-09 | 37 | 103 | 7 | MM14883 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 9.48e-09 | 38 | 103 | 7 | MM15434 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 1.15e-08 | 39 | 103 | 7 | MM14850 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.73e-08 | 237 | 103 | 13 | M27786 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.70e-08 | 246 | 103 | 13 | M10189 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 2.78e-08 | 44 | 103 | 7 | MM15527 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 3.27e-08 | 45 | 103 | 7 | MM15508 | |
| Pathway | REACTOME_DEUBIQUITINATION | H2BC11 H2BC18 TGFBR1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.48e-08 | 299 | 103 | 14 | M27574 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 4.48e-08 | 47 | 103 | 7 | MM15296 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 H2BC18 RIOX2 KANSL3 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 H2BC3 | 5.85e-08 | 175 | 103 | 11 | MM14941 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 6.98e-08 | 50 | 103 | 7 | MM15308 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 9.10e-08 | 323 | 103 | 14 | M27080 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 1.21e-07 | 54 | 103 | 7 | MM14904 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.56e-07 | 56 | 103 | 7 | MM17236 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 1.77e-07 | 57 | 103 | 7 | MM15298 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.92e-07 | 291 | 103 | 13 | M16647 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | H2BC11 MCF2 CPD H2BC12L H2BC1 PTK2B H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 MCF2L MTX1 ARHGAP21 H2BC12 | 2.11e-07 | 720 | 103 | 20 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.34e-07 | 296 | 103 | 13 | M27869 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.58e-07 | 63 | 103 | 7 | MM15613 | |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 4.45e-07 | 65 | 103 | 7 | MM15490 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 5.49e-07 | 67 | 103 | 7 | MM15429 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 9.03e-07 | 72 | 103 | 7 | MM15381 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 1.09e-06 | 74 | 103 | 7 | MM14605 | |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 1.20e-06 | 75 | 103 | 7 | MM15299 | |
| Pathway | REACTOME_M_PHASE | TNPO1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.98e-06 | 417 | 103 | 14 | M27662 |
| Pubmed | Inhibition of core histones acetylation by carcinogenic nickel(II). | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.20e-29 | 18 | 127 | 13 | 16283522 |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.27e-27 | 22 | 127 | 13 | 16713563 | |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.21e-26 | 23 | 127 | 13 | 16307923 | |
| Pubmed | Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.01e-26 | 18 | 127 | 12 | 12757711 |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.70e-22 | 30 | 127 | 12 | 16319397 | |
| Pubmed | Histone H2B as a functionally important plasminogen receptor on macrophages. | 4.25e-19 | 15 | 127 | 9 | 17690254 | |
| Pubmed | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.65e-18 | 77 | 127 | 13 | 12408966 | |
| Pubmed | Quantitative proteomic analysis of post-translational modifications of human histones. | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 2.05e-18 | 17 | 127 | 9 | 16627869 |
| Pubmed | 4.13e-18 | 11 | 127 | 8 | 15197225 | ||
| Pubmed | Histone modifications associated with somatic hypermutation. | 4.13e-18 | 11 | 127 | 8 | 16039583 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.44e-17 | 69 | 127 | 12 | 11689053 |
| Pubmed | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.03e-17 | 73 | 127 | 12 | 14657027 | |
| Pubmed | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.03e-17 | 73 | 127 | 12 | 9566873 | |
| Pubmed | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.02e-16 | 86 | 127 | 12 | 11080476 | |
| Pubmed | H2BC11 H2BC18 H2BC12L TGFBR1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 | 6.29e-15 | 277 | 127 | 16 | 30745168 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | CYP1A2 H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.94e-14 | 203 | 127 | 14 | 16916647 |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | H2BC11 CLPX H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNM1 H2BC12 | 3.74e-14 | 256 | 127 | 15 | 35777956 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 6.11e-14 | 67 | 127 | 10 | 25253489 | |
| Pubmed | 4.78e-13 | 55 | 127 | 9 | 9439656 | ||
| Pubmed | Gene-specific characterization of human histone H2B by electron capture dissociation. | 3.59e-12 | 6 | 127 | 5 | 16457587 | |
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 4.80e-11 | 59 | 127 | 8 | 23254330 | |
| Pubmed | TNPO1 H2BC11 CLPX H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 1.21e-10 | 451 | 127 | 15 | 36168627 | |
| Pubmed | TNPO1 UBR4 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 H2BC5 H2BC3 | 2.94e-10 | 206 | 127 | 11 | 22174317 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.82e-10 | 271 | 127 | 12 | 32433965 |
| Pubmed | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 3.99e-10 | 212 | 127 | 11 | 23463506 | |
| Pubmed | Endotoxin-neutralizing antimicrobial proteins of the human placenta. | 8.45e-10 | 5 | 127 | 4 | 11859126 | |
| Pubmed | Biochemical and antibacterial analysis of human wound and blister fluid. | 8.45e-10 | 5 | 127 | 4 | 8620898 | |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.73e-10 | 438 | 127 | 14 | 21630459 | |
| Pubmed | 1.17e-09 | 14 | 127 | 5 | 10064132 | ||
| Pubmed | H2BC11 UBR4 MUC16 CLPX H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 1.95e-09 | 844 | 127 | 18 | 25963833 | |
| Pubmed | Antimicrobial peptides in the first line defence of human colon mucosa. | 4.95e-09 | 18 | 127 | 5 | 12860195 | |
| Pubmed | 5.88e-09 | 7 | 127 | 4 | 15019208 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | SMG1 H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 1.04e-08 | 626 | 127 | 15 | 33644029 |
| Pubmed | 3.50e-08 | 10 | 127 | 4 | 23746204 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 12511974 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 12383797 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 24273169 | ||
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 4.76e-08 | 3 | 127 | 3 | 28395327 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 12517701 | ||
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 4.76e-08 | 3 | 127 | 3 | 24046449 | |
| Pubmed | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.76e-08 | 425 | 127 | 12 | 21081503 | |
| Pubmed | SMG1 H2BC11 DDX52 UBR4 XPC CLPX H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 NRXN1 H2BC5 H2BC3 MCF2L POFUT2 ARHGAP21 H2BC12 | 6.24e-08 | 1442 | 127 | 21 | 35575683 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TNPO1 H2BC11 ATP6V1B2 ZGRF1 IKBIP H2BC13 H2BC15 H2BC14 H2BC4 H2BC17 MRPS15 DNM3 H2BC5 H2BC3 H2BC12 DNM2 | 8.78e-08 | 847 | 127 | 16 | 35235311 |
| Pubmed | 1.18e-07 | 13 | 127 | 4 | 8858344 | ||
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 1.90e-07 | 4 | 127 | 3 | 21689597 | |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 22846998 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.00e-07 | 477 | 127 | 12 | 31300519 |
| Pubmed | H2BC11 ATP6V1B2 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 H2BC3 | 3.40e-07 | 247 | 127 | 9 | 30713523 | |
| Pubmed | 3.76e-07 | 250 | 127 | 9 | 33536335 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FAT4 PIGK CHSY1 CPD PPP6R1 IKBIP B3GAT3 NOMO1 ITPR1 TGFBR1 SLC38A2 EFEMP1 MEGF8 ADGRE5 UNC93B1 CTNNB1 POFUT2 ARHGAP21 | 4.01e-07 | 1201 | 127 | 18 | 35696571 |
| Pubmed | Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts. | 4.73e-07 | 5 | 127 | 3 | 19380485 | |
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 9722593 | ||
| Pubmed | 8.93e-07 | 88 | 127 | 6 | 26318153 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 23640057 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 27251629 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 18602423 | ||
| Pubmed | Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. | 9.43e-07 | 6 | 127 | 3 | 22967069 | |
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 1.65e-06 | 7 | 127 | 3 | 8858345 | |
| Pubmed | The activity-dependent histone variant H2BE modulates the life span of olfactory neurons. | 1.65e-06 | 7 | 127 | 3 | 23240083 | |
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 15252009 | ||
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 9710638 | ||
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 24282027 | ||
| Pubmed | 3.93e-06 | 9 | 127 | 3 | 23170932 | ||
| Pubmed | Dynamin genes Dnm1 and Dnm2 are located on proximal mouse chromosomes 2 and 9, respectively. | 3.93e-06 | 9 | 127 | 3 | 9143510 | |
| Pubmed | Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway. | 3.93e-06 | 9 | 127 | 3 | 14729481 | |
| Pubmed | Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. | 3.93e-06 | 9 | 127 | 3 | 12857866 | |
| Pubmed | H2BC11 ATP6V1B2 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.27e-06 | 878 | 127 | 14 | 37223481 | |
| Pubmed | H2BC11 H2BC18 H2BC1 KPNA7 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MRPS15 H2BC5 H2BC3 ADGRD1 H2BC12 | 4.98e-06 | 1153 | 127 | 16 | 29845934 | |
| Pubmed | 5.60e-06 | 10 | 127 | 3 | 10398046 | ||
| Pubmed | SLC11A2 PIGK DDX52 UBR4 CHSY1 CPD ITGAX IKBIP B3GAT3 NOMO1 ITPR1 PNPLA6 HELZ2 ADGRE5 ASCC3 DHX34 | 5.86e-06 | 1168 | 127 | 16 | 19946888 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SMG1 H2BC11 ACVR1 NOMO1 TGFBR1 PTK2B H2BC17 H2BC21 DNM3 H2BC3 DDX60L CTNNB1 ARHGAP21 DNM2 | 6.42e-06 | 910 | 127 | 14 | 36736316 |
| Pubmed | Human histone gene organization: nonregular arrangement within a large cluster. | 8.13e-06 | 35 | 127 | 4 | 9119399 | |
| Pubmed | Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder. | 1.32e-05 | 2 | 127 | 2 | 30142896 | |
| Pubmed | Association of ITGAX and ITGAM gene polymorphisms with susceptibility to IgA nephropathy. | 1.32e-05 | 2 | 127 | 2 | 31227791 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 27602957 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 21670293 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 16028072 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11003706 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8573344 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 34283878 | ||
| Pubmed | Dynamin is primed at endocytic sites for ultrafast endocytosis. | 1.32e-05 | 2 | 127 | 2 | 35809574 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 34274446 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 24963135 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15067069 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 32355204 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 26302298 | ||
| Pubmed | An intramolecular signaling element that modulates dynamin function in vitro and in vivo. | 1.32e-05 | 2 | 127 | 2 | 19515832 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 22882618 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 18541300 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 24673776 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 22977254 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 20700106 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 16051744 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 38641407 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8611618 | ||
| Pubmed | Dynamin-mediated lipid acquisition is essential for Chlamydia trachomatis development. | 1.32e-05 | 2 | 127 | 2 | 25116793 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11782545 | ||
| Pubmed | CD11c(+)/CD11b(+) cells are critical for organic dust-elicited murine lung inflammation. | 1.32e-05 | 2 | 127 | 2 | 22822029 | |
| Pubmed | BCL-3 and β-catenin signaling and tumor staging in colorectal cancer. | 1.32e-05 | 2 | 127 | 2 | 33040819 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 22308498 | ||
| Interaction | TNN interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.41e-21 | 23 | 125 | 12 | int:TNN |
| Interaction | CDK5R2 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.23e-19 | 23 | 125 | 11 | int:CDK5R2 |
| Interaction | CYLC1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.02e-17 | 20 | 125 | 10 | int:CYLC1 |
| Interaction | HMGN3 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.07e-16 | 64 | 125 | 13 | int:HMGN3 |
| Interaction | DUOX2 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.58e-15 | 30 | 125 | 10 | int:DUOX2 |
| Interaction | HMGN4 interactions | H2BC11 XPC H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.79e-14 | 100 | 125 | 13 | int:HMGN4 |
| Interaction | TEX35 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.84e-14 | 57 | 125 | 11 | int:TEX35 |
| Interaction | H2BC17 interactions | H2BC11 XPC H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.00e-13 | 140 | 125 | 14 | int:H2BC17 |
| Interaction | FAM47B interactions | 4.96e-13 | 13 | 125 | 7 | int:FAM47B | |
| Interaction | HCLS1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 6.25e-13 | 71 | 125 | 11 | int:HCLS1 |
| Interaction | LOC102724334 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.23e-12 | 134 | 125 | 13 | int:LOC102724334 |
| Interaction | H2BC5 interactions | H2BC11 DDX52 XPC SMG5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TRPM8 H2BC12 DNM2 | 2.33e-12 | 331 | 125 | 18 | int:H2BC5 |
| Interaction | DPPA2 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.36e-12 | 40 | 125 | 9 | int:DPPA2 |
| Interaction | H2AC7 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.85e-12 | 107 | 125 | 12 | int:H2AC7 |
| Interaction | H2AC25 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.23e-12 | 84 | 125 | 11 | int:H2AC25 |
| Interaction | H2BC1 interactions | H2BC11 XPC IKBIP H2BC18 H2BC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.49e-12 | 178 | 125 | 14 | int:H2BC1 |
| Interaction | H2BC15 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.65e-12 | 144 | 125 | 13 | int:H2BC15 |
| Interaction | ZNF474 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 5.99e-12 | 44 | 125 | 9 | int:ZNF474 |
| Interaction | HMGN2 interactions | H2BC11 DDX52 CLPX H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.26e-12 | 222 | 125 | 15 | int:HMGN2 |
| Interaction | PCLO interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 TMEM132D H2BC5 H2BC12 | 1.69e-11 | 70 | 125 | 10 | int:PCLO |
| Interaction | H2BC14 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.97e-11 | 100 | 125 | 11 | int:H2BC14 |
| Interaction | H2AC6 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.97e-11 | 100 | 125 | 11 | int:H2AC6 |
| Interaction | H2BC13 interactions | H2BC11 SMG5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.11e-11 | 210 | 125 | 14 | int:H2BC13 |
| Interaction | H2BC18 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.55e-11 | 180 | 125 | 13 | int:H2BC18 |
| Interaction | H2BC26 interactions | H2BC11 XPC H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.17e-10 | 183 | 125 | 13 | int:H2BC26 |
| Interaction | JPH2 interactions | 1.31e-10 | 25 | 125 | 7 | int:JPH2 | |
| Interaction | H2AC18 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 DNM2 | 1.36e-10 | 148 | 125 | 12 | int:H2AC18 |
| Interaction | H2BC11 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.44e-10 | 186 | 125 | 13 | int:H2BC11 |
| Interaction | H2AC12 interactions | H2BC11 H2BC18 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 | 1.83e-10 | 118 | 125 | 11 | int:H2AC12 |
| Interaction | H2AC1 interactions | 5.47e-10 | 71 | 125 | 9 | int:H2AC1 | |
| Interaction | SFMBT2 interactions | 8.82e-10 | 32 | 125 | 7 | int:SFMBT2 | |
| Interaction | H2AC13 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.04e-10 | 75 | 125 | 9 | int:H2AC13 |
| Interaction | UBA52 interactions | H2BC11 SMURF1 ACVR1 H2BC18 TGFBR1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 | 1.78e-09 | 437 | 125 | 17 | int:UBA52 |
| Interaction | H2BC21 interactions | TNPO1 H2BC11 DDX52 SMURF1 XPC SMG5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DDX60L DNAH5 H2BC12 SENP7 | 1.83e-09 | 696 | 125 | 21 | int:H2BC21 |
| Interaction | IGSF8 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 DNM3 H2BC5 H2BC3 H2BC12 DNM2 | 3.13e-09 | 239 | 125 | 13 | int:IGSF8 |
| Interaction | PSMD14 interactions | H2BC11 UBR4 ACVR1 H2BC18 H2BC12L TGFBR1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 | 4.42e-09 | 527 | 125 | 18 | int:PSMD14 |
| Interaction | H2AC11 interactions | H2BC11 XPC H2BC18 H2BC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.89e-09 | 248 | 125 | 13 | int:H2AC11 |
| Interaction | RPS27A interactions | H2BC11 SMURF1 ACVR1 H2BC18 KANSL3 TGFBR1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 5.75e-09 | 536 | 125 | 18 | int:RPS27A |
| Interaction | MAP1B interactions | TNPO1 H2BC11 UBR4 SMURF1 CLPX H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNM1 H2BC12 | 6.27e-09 | 539 | 125 | 18 | int:MAP1B |
| Interaction | H2AC4 interactions | H2BC11 DDX52 XPC H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 DNM2 | 1.57e-08 | 506 | 125 | 17 | int:H2AC4 |
| Interaction | H2AC14 interactions | H2BC11 H2BC18 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.23e-08 | 144 | 125 | 10 | int:H2AC14 |
| Interaction | H2BC3 interactions | H2BC11 USP43 XPC H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.41e-08 | 406 | 125 | 15 | int:H2BC3 |
| Interaction | MCM5 interactions | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 5.32e-08 | 420 | 125 | 15 | int:MCM5 |
| Interaction | ICAM1 interactions | H2BC11 ITGAM H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 5.68e-08 | 252 | 125 | 12 | int:ICAM1 |
| Interaction | H2BC4 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.67e-08 | 259 | 125 | 12 | int:H2BC4 |
| Interaction | HMGN1 interactions | H2BC11 XPC H2BC18 H2BC1 H2BC13 H2BC9 H2BC4 H2BC5 ARHGAP21 H2BC12 | 9.64e-08 | 168 | 125 | 10 | int:HMGN1 |
| Interaction | TMEM196 interactions | 9.69e-08 | 8 | 125 | 4 | int:TMEM196 | |
| Interaction | H2AJ interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.73e-08 | 127 | 125 | 9 | int:H2AJ |
| Interaction | ELK4 interactions | 1.05e-07 | 92 | 125 | 8 | int:ELK4 | |
| Interaction | H2BC12 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.07e-07 | 322 | 125 | 13 | int:H2BC12 |
| Interaction | H2BC9 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CROCC DNAH5 H2BC12 | 1.16e-07 | 446 | 125 | 15 | int:H2BC9 |
| Interaction | H3C1 interactions | H2BC11 FAT4 DDX52 UBR4 XPC CLPX H2BC18 H2BC1 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 TMEM132D DNM3 SENP6 H2BC5 H2BC3 CTNNB1 H2BC12 | 1.57e-07 | 901 | 125 | 21 | int:H3C1 |
| Interaction | PDS5B interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.66e-07 | 178 | 125 | 10 | int:PDS5B |
| Interaction | UBB interactions | CFAP47 H2BC11 SMURF1 H2BC18 TGFBR1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.10e-07 | 467 | 125 | 15 | int:UBB |
| Interaction | ARHGAP24 interactions | TNPO1 H2BC11 CLPX H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 3.49e-07 | 486 | 125 | 15 | int:ARHGAP24 |
| Interaction | FER interactions | 6.41e-07 | 50 | 125 | 6 | int:FER | |
| Interaction | ADAMTS12 interactions | 1.14e-06 | 55 | 125 | 6 | int:ADAMTS12 | |
| Interaction | CROCCP2 interactions | 1.83e-06 | 15 | 125 | 4 | int:CROCCP2 | |
| Interaction | H2AC21 interactions | H2BC11 XPC H2BC18 H2BC1 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 | 2.03e-06 | 234 | 125 | 10 | int:H2AC21 |
| Interaction | HMGA1 interactions | H2BC11 XPC H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.10e-06 | 419 | 125 | 13 | int:HMGA1 |
| Interaction | IPO9 interactions | TNPO1 H2BC18 H2BC1 H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 2.19e-06 | 236 | 125 | 10 | int:IPO9 |
| Interaction | CD81 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 3.00e-06 | 303 | 125 | 11 | int:CD81 |
| Interaction | H2AZ1 interactions | H2BC11 XPC H2BC18 H2BC1 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.45e-06 | 371 | 125 | 12 | int:H2AZ1 |
| Interaction | CC2D1B interactions | 3.61e-06 | 38 | 125 | 5 | int:CC2D1B | |
| Interaction | ALG5 interactions | 4.78e-06 | 70 | 125 | 6 | int:ALG5 | |
| Interaction | H2AC20 interactions | H2BC11 XPC H2BC18 H2BC1 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.06e-06 | 320 | 125 | 11 | int:H2AC20 |
| Interaction | H3C15 interactions | 5.85e-06 | 207 | 125 | 9 | int:H3C15 | |
| Interaction | USF3 interactions | 6.33e-06 | 20 | 125 | 4 | int:USF3 | |
| Interaction | EIF1AX interactions | 6.68e-06 | 113 | 125 | 7 | int:EIF1AX | |
| Interaction | DOK2 interactions | 7.95e-06 | 116 | 125 | 7 | int:DOK2 | |
| Interaction | BTF3 interactions | SMG1 H2BC11 H2BC18 ITPR1 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 ASCC3 H2BC12 | 9.02e-06 | 799 | 125 | 17 | int:BTF3 |
| Interaction | TMA7 interactions | 9.47e-06 | 46 | 125 | 5 | int:TMA7 | |
| Interaction | USP16 interactions | 9.69e-06 | 79 | 125 | 6 | int:USP16 | |
| Interaction | H2AZ2 interactions | 1.01e-05 | 168 | 125 | 8 | int:H2AZ2 | |
| Interaction | ADARB1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ADGRE5 H2BC12 | 1.11e-05 | 489 | 125 | 13 | int:ADARB1 |
| Interaction | PDCD4 interactions | 1.42e-05 | 176 | 125 | 8 | int:PDCD4 | |
| Interaction | SKAP2 interactions | 1.58e-05 | 51 | 125 | 5 | int:SKAP2 | |
| Interaction | H2AX interactions | H2BC11 XPC H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.91e-05 | 593 | 125 | 14 | int:H2AX |
| Interaction | H3-4 interactions | TNPO1 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 DNM3 H2BC5 DNAH5 H2BC12 | 2.29e-05 | 448 | 125 | 12 | int:H3-4 |
| Interaction | MAPK7 interactions | 3.10e-05 | 143 | 125 | 7 | int:MAPK7 | |
| Interaction | SPON2 interactions | 3.71e-05 | 11 | 125 | 3 | int:SPON2 | |
| Interaction | ZBBX interactions | 3.90e-05 | 31 | 125 | 4 | int:ZBBX | |
| Interaction | RIOK1 interactions | H2BC11 SMURF1 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.75e-05 | 562 | 125 | 13 | int:RIOK1 |
| Interaction | TOMM70 interactions | 4.78e-05 | 153 | 125 | 7 | int:TOMM70 | |
| Interaction | MACROH2A2 interactions | 5.21e-05 | 211 | 125 | 8 | int:MACROH2A2 | |
| Interaction | SECISBP2L interactions | 5.66e-05 | 34 | 125 | 4 | int:SECISBP2L | |
| Interaction | H4C9 interactions | 5.76e-05 | 108 | 125 | 6 | int:H4C9 | |
| Interaction | TIMM44 interactions | H2BC13 H2BC9 H2BC4 H2BC17 H2BC5 ROS1 UNC93B1 ARHGAP21 H2BC12 | 6.36e-05 | 280 | 125 | 9 | int:TIMM44 |
| Interaction | H4C7 interactions | 6.36e-05 | 35 | 125 | 4 | int:H4C7 | |
| Interaction | MAGIX interactions | 6.36e-05 | 35 | 125 | 4 | int:MAGIX | |
| Interaction | MAP7D2 interactions | 7.43e-05 | 70 | 125 | 5 | int:MAP7D2 | |
| Interaction | H3-5 interactions | 7.79e-05 | 114 | 125 | 6 | int:H3-5 | |
| Interaction | MEPCE interactions | H2BC11 H2BC18 H2BC1 KPNA7 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MRPS15 H2BC5 H2BC3 H2BC12 DNM2 | 8.33e-05 | 859 | 125 | 16 | int:MEPCE |
| Interaction | PTPRM interactions | 8.50e-05 | 72 | 125 | 5 | int:PTPRM | |
| Interaction | H1-6 interactions | 9.25e-05 | 229 | 125 | 8 | int:H1-6 | |
| Interaction | GOLT1B interactions | 1.07e-04 | 234 | 125 | 8 | int:GOLT1B | |
| Interaction | USP45 interactions | 1.08e-04 | 40 | 125 | 4 | int:USP45 | |
| Interaction | MCM2 interactions | H2BC11 UBR4 MUC16 CLPX H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CTNNB1 H2BC12 | 1.21e-04 | 1081 | 125 | 18 | int:MCM2 |
| Interaction | MACROH2A1 interactions | TNPO1 SMURF1 XPC H2BC1 H2BC15 H2BC9 H2BC4 H2BC21 H2BC3 ROS1 H2BC12 | 1.34e-04 | 458 | 125 | 11 | int:MACROH2A1 |
| Interaction | LCK interactions | SMURF1 H2BC18 PTK2B H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 LTB4R ARHGAP21 DNM2 | 1.48e-04 | 463 | 125 | 11 | int:LCK |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 9.67e-09 | 378 | 127 | 11 | chr6p22 |
| Cytoband | 6p22.1 | 2.99e-06 | 142 | 127 | 6 | 6p22.1 | |
| Cytoband | 1p36.13 | 5.15e-04 | 56 | 127 | 3 | 1p36.13 | |
| Cytoband | 1q21.2 | 1.03e-03 | 71 | 127 | 3 | 1q21.2 | |
| Cytoband | 8p21.1 | 1.40e-03 | 20 | 127 | 2 | 8p21.1 | |
| GeneFamily | Histones | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.86e-15 | 116 | 98 | 14 | 864 |
| GeneFamily | Type 1 receptor serine/threonine kinases | 5.32e-06 | 7 | 98 | 3 | 345 | |
| GeneFamily | SUMO specific peptidases | 6.00e-04 | 7 | 98 | 2 | 984 | |
| GeneFamily | Complement system|Sushi domain containing | 9.68e-04 | 36 | 98 | 3 | 492 | |
| GeneFamily | UPF1 like RNA helicases | 1.55e-03 | 11 | 98 | 2 | 1169 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 4.20e-03 | 18 | 98 | 2 | 1160 | |
| GeneFamily | Armadillo repeat containing|Importins | 4.20e-03 | 18 | 98 | 2 | 596 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.28e-03 | 206 | 98 | 5 | 682 | |
| GeneFamily | Solute carriers | 5.68e-03 | 395 | 98 | 7 | 752 | |
| Coexpression | HASLINGER_B_CLL_WITH_6Q21_DELETION | 3.37e-06 | 22 | 125 | 4 | M7362 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | ATP6V1B2 SLC11A2 PHTF2 TCIRG1 CPD CLPX ITGAX ITPR1 PLPP1 SENP6 H2BC12 | 3.48e-06 | 399 | 125 | 11 | M41172 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | H2BC11 CHSY1 RIOX2 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 EFEMP1 H2BC17 H2BC21 H2BC5 H2BC3 DDX60L H2BC12 | 4.01e-06 | 768 | 125 | 15 | M6444 |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN | 5.28e-06 | 199 | 125 | 8 | M9954 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | 5.48e-06 | 200 | 125 | 8 | M9952 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.57e-05 | 111 | 125 | 6 | MM705 | |
| Coexpression | HOXA9_DN.V1_UP | 3.90e-05 | 192 | 125 | 7 | M2850 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 4.75e-05 | 198 | 125 | 7 | MM17083 | |
| Coexpression | GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP | 4.90e-05 | 199 | 125 | 7 | M5105 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN | 4.90e-05 | 199 | 125 | 7 | M9920 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_NKCELL_UP | 4.90e-05 | 199 | 125 | 7 | M5530 | |
| Coexpression | GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP | 5.06e-05 | 200 | 125 | 7 | M7207 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP | 5.06e-05 | 200 | 125 | 7 | M5416 | |
| Coexpression | ALCALAY_AML_BY_NPM1_LOCALIZATION_UP | 5.81e-05 | 140 | 125 | 6 | M9377 | |
| Coexpression | GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS | 6.48e-05 | 208 | 125 | 7 | M39139 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL | 9.72e-05 | 384 | 125 | 9 | M45735 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN | 9.73e-05 | 222 | 125 | 7 | M16955 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 9.84e-05 | 96 | 125 | 5 | M1683 | |
| Coexpression | HALLMARK_TGF_BETA_SIGNALING | 1.30e-04 | 54 | 125 | 4 | M5896 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 1.31e-04 | 102 | 125 | 5 | M10290 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | H2BC11 SLC11A2 RTTN XPC H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 1.62e-04 | 714 | 125 | 12 | M1744 |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | 2.31e-08 | 32 | 120 | 6 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K1 | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC12 | 3.83e-08 | 125 | 120 | 9 | facebase_RNAseq_e9.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | 1.38e-07 | 70 | 120 | 7 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | 3.73e-07 | 50 | 120 | 6 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 3.04e-06 | 110 | 120 | 7 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | 3.31e-06 | 72 | 120 | 6 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | H2BC11 SDK2 GRID2 BCL3 IDUA H2BC18 H2BC1 H2BC15 H2BC14 MTMR11 H2BC4 H2BC21 NRXN1 DNM3 H2BC3 CCL19 MCF2L SENP7 | 8.30e-06 | 968 | 120 | 18 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K2 | 1.34e-05 | 54 | 120 | 5 | facebase_RNAseq_e9.5_FaceMes_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | H2BC11 ANO9 USP43 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC12 SLC44A3 | 1.79e-05 | 402 | 120 | 11 | facebase_RNAseq_e10.5_OlfacPit_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | 1.91e-05 | 58 | 120 | 5 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.19e-05 | 268 | 120 | 9 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K3 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | 3.82e-05 | 162 | 120 | 7 | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | ADGRG3 ZGRF1 XPC ITGAM ITPR1 H2BC13 H2BC14 H2BC9 H2BC3 UNC93B1 | 7.21e-05 | 388 | 120 | 10 | GSM538352_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 9.09e-05 | 80 | 120 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | 1.01e-04 | 43 | 120 | 4 | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | GRID2 BCL3 IDUA H2BC18 H2BC1 H2BC15 H2BC14 MTMR11 H2BC4 H2BC21 NRXN1 DNM3 H2BC3 CCL19 MCF2L SENP7 | 1.10e-04 | 967 | 120 | 16 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.72e-04 | 275 | 120 | 8 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500 | H2BC11 ANO9 USP43 PHTF2 RTN4RL1 WDR54 ACVR1C H2BC18 TGFBR1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 NRXN1 H2BC5 H2BC3 MCF2L H2BC12 SLC44A3 | 1.80e-04 | 1453 | 120 | 20 | facebase_RNAseq_e10.5_OlfacPit_2500 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | 2.13e-04 | 52 | 120 | 4 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | 2.71e-04 | 157 | 120 | 6 | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.93e-04 | 236 | 120 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 4.04e-04 | 110 | 120 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3 | 4.62e-04 | 401 | 120 | 9 | GSM791114_500 | |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Bone marrow, avg-2 | 4.87e-04 | 404 | 120 | 9 | GSM791129_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.BM, B220neg CD3neg CD115+ Ly-6C/Glo CD43+, Bone marrow, avg-3 | 5.32e-04 | 409 | 120 | 9 | GSM854332_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 5.42e-04 | 410 | 120 | 9 | GSM538387_500 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.17e-09 | 192 | 126 | 9 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-07 | 200 | 126 | 8 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.74e-07 | 143 | 126 | 7 | 10955b54e4a87d035093a2756291ef1d6a14ab63 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.66e-07 | 178 | 126 | 7 | afcc92e8fe313c85eaf617cf4dbc3058da6c99d6 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.66e-07 | 178 | 126 | 7 | bd689205bc92cda5f71df64c2332ff76adcd84b4 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.25e-07 | 180 | 126 | 7 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.25e-07 | 180 | 126 | 7 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.91e-07 | 185 | 126 | 7 | 698ff44fd2d9b3ad5cea45f4cff9bfc64c559b62 | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-06 | 186 | 126 | 7 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-06 | 186 | 126 | 7 | 981116561986f94e9cc3ee64fb37dab9a31d427a | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-06 | 189 | 126 | 7 | 5a9c3c61998efc40a5d2042e0f568b52103734a9 | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 1.27e-06 | 192 | 126 | 7 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 193 | 126 | 7 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 1.32e-06 | 193 | 126 | 7 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 1.41e-06 | 195 | 126 | 7 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.46e-06 | 196 | 126 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | (5)_Dendritic_cell-(53)_Lymphoid_DC|(5)_Dendritic_cell / shred on Cell_type and subtype | 1.56e-06 | 198 | 126 | 7 | 548da5fa86f9756c503ed77bcdde55bc4d1a2726 | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.61e-06 | 199 | 126 | 7 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 1.61e-06 | 199 | 126 | 7 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-06 | 199 | 126 | 7 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.61e-06 | 137 | 126 | 6 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.72e-06 | 138 | 126 | 6 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.77e-06 | 146 | 126 | 6 | 447c05414eda71681a0c07baba900f88ed6165ed | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.51e-06 | 156 | 126 | 6 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Platelet|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.38e-06 | 160 | 126 | 6 | 768f3cefc3ad4cda229e598cce8bde574cf64bb2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.60e-06 | 165 | 126 | 6 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.15e-06 | 167 | 126 | 6 | 9b9b4cad0b35d121256176600ea4705759c105d3 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-06 | 171 | 126 | 6 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-06 | 171 | 126 | 6 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-06 | 173 | 126 | 6 | a5b6c3d58f7a8e533330798b81496009a31548af | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-06 | 173 | 126 | 6 | cc094992b8027f4cef38f0fb0b76f0d07210d1e2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 174 | 126 | 6 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 174 | 126 | 6 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-05 | 175 | 126 | 6 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | facs-Trachea-3m-Hematologic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-05 | 177 | 126 | 6 | c9d235fc518b291ed98088a1206d14d6692bc7fd | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 179 | 126 | 6 | b88791dd4e73bb8410ca090938a1a45b0bc16e69 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 179 | 126 | 6 | c063028b82c68d929aef2421daade9dc189a6963 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 182 | 126 | 6 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 182 | 126 | 6 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 182 | 126 | 6 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R-_NK_cell|lymphoid / Lineage, cell class and subclass | 1.41e-05 | 184 | 126 | 6 | 62a3918705a3fcf3ef25c9ceb80f575a2e56ef76 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 185 | 126 | 6 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | mild_COVID-19-Platelet|World / disease group, cell group and cell class (v2) | 1.65e-05 | 189 | 126 | 6 | 038ec3c266b89416bb5b774ba522d916394961da | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 1.65e-05 | 189 | 126 | 6 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.70e-05 | 190 | 126 | 6 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|World / disease group, cell group and cell class (v2) | 1.70e-05 | 190 | 126 | 6 | 7aaf82f0c235363afb95cf1fa51c2a5b070b1af8 | |
| ToppCell | URO|World / Disease, Lineage and Cell Type | 1.85e-05 | 193 | 126 | 6 | 421dc0996c6c973f88e90197b651255ae4dd13a2 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-05 | 193 | 126 | 6 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-NK|normal_Lymph_Node / Location, Cell class and cell subclass | 2.02e-05 | 196 | 126 | 6 | 00ab4a1547752d419aa720b39b94a4ab2ede963a | |
| ToppCell | BL-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.08e-05 | 197 | 126 | 6 | 932a7fae4979b561688e6222505df0f4e510ab11 | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.08e-05 | 197 | 126 | 6 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.08e-05 | 197 | 126 | 6 | f38037dfa6c33e9336130d0cc65eaba0f120efb9 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.14e-05 | 198 | 126 | 6 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | NS-critical-d_07-13-Myeloid|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.14e-05 | 198 | 126 | 6 | 08bc3f63a5c5b65bff10aadebdaa5e7f192cda01 | |
| ToppCell | severe-Myeloid-Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.14e-05 | 198 | 126 | 6 | 636878836678a0715550fa09f2e3dac11c4d73fe | |
| ToppCell | moderate-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.14e-05 | 198 | 126 | 6 | a6306dac34af5783f3a734ef1eaa7a0c03267b4f | |
| ToppCell | NS-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.14e-05 | 198 | 126 | 6 | e56417073e83061a43b9c41d6232d653904c1e90 | |
| ToppCell | NS-critical-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.14e-05 | 198 | 126 | 6 | 72d51284d267f102c26f0ae8279ee9e11e69c7e3 | |
| ToppCell | critical-Myeloid-Neutrophil|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.14e-05 | 198 | 126 | 6 | 4da73dc3acb29d70b160903600d2bf7fdab34333 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.20e-05 | 199 | 126 | 6 | a24a319d3ba8f4759f742af27610b4d62e359a2d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-05 | 199 | 126 | 6 | da7cf363712ecec4fb90e3881eb585b7eea13fe7 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_only / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | 3504aeba7b30cac9c428ba3871c072e2202752b4 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.26e-05 | 200 | 126 | 6 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.26e-05 | 200 | 126 | 6 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Biopsy_Other_PF-Immune-Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.26e-05 | 200 | 126 | 6 | 9ff5f0371aac2ab528b581fe979a1522579b8b84 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.26e-05 | 200 | 126 | 6 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells|LPS_only / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | c5afebbc16024c60e84a67be81c78b0bfb73ec68 | |
| ToppCell | moderate-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.44e-05 | 130 | 126 | 5 | a04057bd4f256d09eca06b8c1e8b41425bb4ef3f | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.42e-05 | 137 | 126 | 5 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.90e-05 | 140 | 126 | 5 | 8abbd5dc799943b49cd0045d0da405c3f3d0db6b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.90e-05 | 140 | 126 | 5 | e4689232c473d239b07a7fbcaaa3414fbd9badea | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-05 | 143 | 126 | 5 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-05 | 144 | 126 | 5 | 5665dd2839b6c8ddbf5ddb2d22e1ee6073f74c3b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.18e-05 | 147 | 126 | 5 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.47e-05 | 153 | 126 | 5 | 489228ab81c3ae339a53a9da6c2a1c1b6ac3f84b | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-05 | 155 | 126 | 5 | d0c1608f8f6b6f4174e51d610501c707cba5e015 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 8.19e-05 | 156 | 126 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.44e-05 | 157 | 126 | 5 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.69e-05 | 158 | 126 | 5 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-05 | 159 | 126 | 5 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.22e-05 | 160 | 126 | 5 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 162 | 126 | 5 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 162 | 126 | 5 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 164 | 126 | 5 | b1a6f56207cb0fbd3f99225d4a7354a17aa26362 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 164 | 126 | 5 | f3684d029ca58b782e3e87f79e56069b42b22fdd | |
| ToppCell | facs-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 165 | 126 | 5 | a359dda24c2c10b7b8df902a7c4c2ebf27b041f3 | |
| ToppCell | facs-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 165 | 126 | 5 | 1d5880aa49e6e6e95bde14a40fbe6e40b71c6d22 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 165 | 126 | 5 | 8a3cfec76cc7c5a309d582becd1aef4261b7f4e1 | |
| ToppCell | facs-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 165 | 126 | 5 | cdc09cbfd6eaeb8e436d83bbca7146bde3b3f01e | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 165 | 126 | 5 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 166 | 126 | 5 | 2887f4f0c218cbcbcc82eef27aa4ee714b35cddb | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 166 | 126 | 5 | 1cc291a04f4144abba4aca7badeb7776db05d903 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 167 | 126 | 5 | 991a93e1075d562b7391f0689b2f62c1351d48d1 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 167 | 126 | 5 | f22d1471c785b30d096ec5cdc68974e850ed7de0 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 167 | 126 | 5 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 167 | 126 | 5 | 934905aeaafbc215ec8f6a7903498b0e258b9220 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 167 | 126 | 5 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 168 | 126 | 5 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 169 | 126 | 5 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 169 | 126 | 5 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| Computational | Genes in the cancer module 89. | 2.31e-06 | 14 | 77 | 4 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 4.15e-06 | 16 | 77 | 4 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 5.40e-06 | 17 | 77 | 4 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 6.90e-06 | 18 | 77 | 4 | MODULE_552 | |
| Computational | Genes in the cancer module 534. | 6.90e-06 | 18 | 77 | 4 | MODULE_534 | |
| Computational | Genes in the cancer module 222. | 1.61e-05 | 22 | 77 | 4 | MODULE_222 | |
| Computational | Genes in the cancer module 168. | 1.61e-05 | 22 | 77 | 4 | MODULE_168 | |
| Computational | Genes in the cancer module 189. | 1.94e-05 | 23 | 77 | 4 | MODULE_189 | |
| Computational | Genes in the cancer module 127. | 3.23e-05 | 26 | 77 | 4 | MODULE_127 | |
| Computational | Chromatin. | 4.37e-05 | 28 | 77 | 4 | MODULE_421 | |
| Computational | Neighborhood of ITGB2 | 7.21e-04 | 57 | 77 | 4 | GNF2_ITGB2 | |
| Drug | Methylmethacrylate | 6.24e-13 | 39 | 125 | 9 | ctd:D020366 | |
| Drug | Berberine | CYP1A2 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 CTNNB1 H2BC12 | 1.57e-08 | 202 | 125 | 11 | ctd:D001599 |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.93e-06 | 160 | 125 | 8 | 5364_UP | |
| Drug | library 2 | 3.15e-06 | 19 | 125 | 4 | CID005270634 | |
| Drug | Methylazoxymethanol Acetate | 3.31e-06 | 74 | 125 | 6 | ctd:D008746 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 3.85e-06 | 166 | 125 | 8 | 3290_UP | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 4.20e-06 | 168 | 125 | 8 | 2801_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 8.55e-06 | 185 | 125 | 8 | 6945_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; PC3; HT_HG-U133A | 1.30e-05 | 196 | 125 | 8 | 4570_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.35e-05 | 197 | 125 | 8 | 7037_DN | |
| Drug | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | 3.37e-05 | 291 | 125 | 9 | ctd:C044387 | |
| Drug | Go7874 | 3.43e-05 | 12 | 125 | 3 | CID005327863 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 6.20e-07 | 5 | 118 | 3 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 6.20e-07 | 5 | 118 | 3 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 6.20e-07 | 5 | 118 | 3 | DOID:0110197 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 1.34e-05 | 12 | 118 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.73e-05 | 13 | 118 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Inguinal hernia | 2.11e-05 | 287 | 118 | 8 | HP_0000023 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 2.66e-05 | 43 | 118 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | melanoma | 6.50e-05 | 248 | 118 | 7 | C0025202 | |
| Disease | behavioural disinhibition measurement | 2.37e-04 | 75 | 118 | 4 | EFO_0006946 | |
| Disease | acute myocardial infarction (is_marker_for) | 3.29e-04 | 7 | 118 | 2 | DOID:9408 (is_marker_for) | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 4.37e-04 | 8 | 118 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 5.39e-04 | 93 | 118 | 4 | C1535926 | |
| Disease | Liver Cirrhosis | 7.92e-04 | 103 | 118 | 4 | C0023890 | |
| Disease | Fibrosis, Liver | 8.51e-04 | 105 | 118 | 4 | C0239946 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 1.53e-03 | 123 | 118 | 4 | EFO_0007789, EFO_0008002 | |
| Disease | obesity (implicated_via_orthology) | 1.76e-03 | 215 | 118 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | osteoarthritis | 2.03e-03 | 222 | 118 | 5 | MONDO_0005178 | |
| Disease | bilirubin measurement | 2.05e-03 | 442 | 118 | 7 | EFO_0004570 | |
| Disease | Multiple congenital anomalies | 2.07e-03 | 17 | 118 | 2 | C0000772 | |
| Disease | Malignant neoplasm of liver | 2.58e-03 | 142 | 118 | 4 | C0345904 | |
| Disease | Liver neoplasms | 2.58e-03 | 142 | 118 | 4 | C0023903 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 2.59e-03 | 19 | 118 | 2 | OBA_2045199 | |
| Disease | asthma | 3.25e-03 | 751 | 118 | 9 | MONDO_0004979 | |
| Disease | otitis media (implicated_via_orthology) | 3.48e-03 | 22 | 118 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | Primary microcephaly | 3.48e-03 | 22 | 118 | 2 | C0431350 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RALIISPTRELASQI | 236 | Q9Y2R4 | |
| AELVRLSQTLSLVPR | 91 | O94766 | |
| ILLSTVALRGAVTLP | 86 | Q8N8Q8 | |
| LGTFETQILQRAPLR | 41 | O76031 | |
| QVLLLISFRLEPGTT | 616 | Q6QNK2 | |
| NLGTLPRTILQVVAR | 2271 | Q6V0I7 | |
| ILTFLLVRPIQGSRT | 566 | P48960 | |
| SGLPLLVQRTIARTI | 181 | Q8NER5 | |
| LPFLVQRTVARQITL | 196 | Q04771 | |
| LPGNRSVVRLAVTIL | 141 | Q86Y34 | |
| RVIVIRSPVLQIGSL | 411 | Q8N302 | |
| RSPVLQIGSLFIITA | 416 | Q8N302 | |
| TIPVTTSLRIRIVNF | 111 | A1A5B4 | |
| ITITRLVVGFLLPSV | 336 | Q16581 | |
| TSREIQTAVRLLLPG | 91 | P57053 | |
| FISDALVLRRTILPT | 341 | Q2TB18 | |
| RQLRTLAPETFQGLV | 111 | Q86UN2 | |
| LQIRIGSTPVLVLSR | 76 | P05177 | |
| TSREIQTAVRLLLPG | 91 | Q16778 | |
| TSREIQTAVRLLLPG | 91 | Q5QNW6 | |
| SVTPITLRLNFTLVG | 726 | P20702 | |
| TSREIQTAVRLLLPG | 91 | P06899 | |
| TSREIQTAVRLLLPG | 91 | Q99877 | |
| NTTERVLQGLLRPLF | 13816 | Q8WXI7 | |
| VLTGEPLIFTLRAQR | 586 | Q8IY17 | |
| NRIVIRGLNTIPLFV | 586 | P35222 | |
| LISPTLPITFLRNIT | 206 | A9QM74 | |
| VQRLGLTPTTVIRLN | 106 | Q9NPJ1 | |
| VARRLLLTGFPQTTL | 456 | Q9HCP6 | |
| TSREIQTAVRLLLPG | 91 | Q99879 | |
| ASTILRLIFSVGLQP | 2346 | Q14643 | |
| LEAVSGLSRVQLLRP | 106 | A4FU01 | |
| SGIVTRRPLVLQLVN | 61 | Q05193 | |
| RVPAVVFTTLRGRQL | 56 | Q99731 | |
| ELRGQFPLSITLVLR | 1341 | Q5H9U9 | |
| SGIVTRRPLVLQLVT | 61 | Q9UQ16 | |
| TSREIQTAVRLLLPG | 91 | P58876 | |
| TSREIQTAVRLLLPG | 91 | Q93079 | |
| TSREIQTAVRLLLPG | 91 | O60814 | |
| RSIGRLTIIRQTFPV | 276 | O43424 | |
| RSIPLVQVLRTTALT | 511 | P29122 | |
| VFLRGFVSILPVILR | 146 | Q9Y5P1 | |
| IPLLLQLTSRLQGVR | 1181 | Q15155 | |
| RDRPLTVQALSGLLV | 1371 | Q7Z7M0 | |
| RVVLTRSIAIIPTLL | 411 | P49281 | |
| LILTRGGRLQLSFSI | 81 | Q9ULB1 | |
| FIITTILRIPSAEGR | 221 | Q9NQN1 | |
| SGIVTRRPLILQLIF | 61 | P50570 | |
| VTVENFLRVLTGRIP | 126 | Q92643 | |
| PLVNDLTLRIGRLVT | 296 | Q70UQ0 | |
| SRRTGRLVVLIILTF | 216 | Q15722 | |
| LLTTLVPLFRNSRLV | 311 | Q86YD1 | |
| LDQIATLIGPTRLRI | 376 | Q9QC07 | |
| LRVARSVLPLSVVFI | 111 | Q96A29 | |
| ISSREIQTAVRLLLP | 91 | Q96A08 | |
| TSREIQTAVRLLLPG | 91 | P33778 | |
| TSREIQTAVRLLLPG | 91 | P62807 | |
| LLRVVRASSIFPILS | 121 | Q8WXS5 | |
| SLPALIREIVTRNLS | 46 | Q5TZA2 | |
| LRIVRASSVFPILST | 101 | Q9UBN1 | |
| TSREIQTAVRLLLPG | 91 | Q99880 | |
| TSREIQTAVRLLLPG | 91 | P23527 | |
| RTVSNLILTGPRTIV | 386 | Q8TB45 | |
| RLLVPGTYNLTVVLT | 421 | O75976 | |
| LRPQTLLRVGSVVLS | 96 | Q9NVV2 | |
| VTRLRALPLTQGQLV | 551 | P35475 | |
| QLVLVLRPTGFFQRT | 161 | O15068 | |
| LVLVLRPTSFLQRTF | 26 | P10911 | |
| ITLTLRGQPSRITTL | 861 | Q9P2N6 | |
| GSFLISVVRIPRIIV | 441 | Q8N4M1 | |
| PRIRFLVIRSSAISI | 111 | O60931 | |
| GFSRQVRATVLLLLP | 71 | Q5T1A1 | |
| VRATVLLLLPQAFSR | 76 | Q5T1A1 | |
| LTSREVQTAVRLLLP | 86 | A0A2R8Y619 | |
| ITSILLSGRIGPNIR | 71 | Q14289 | |
| ILPGRQFRVVVLSTV | 861 | Q9BYK8 | |
| ITTLPSVVRLLVTAG | 181 | P20749 | |
| TVGLLLRQIQREPSL | 256 | Q14147 | |
| GILFPEVRTTSVRLI | 1306 | Q58EX2 | |
| LILVGIFILAVSRPR | 71 | Q6ZMJ2 | |
| RITTRIGLQSTIVIP | 2751 | Q6ZTR5 | |
| GVRRTQLFPLFIRLV | 236 | Q9P1A2 | |
| ISRVIRTPQGNALLV | 2941 | Q8TE73 | |
| ILITGQIRARPFLSV | 316 | Q8N6C8 | |
| IPRFLVTVVTGNRTI | 76 | A6NL08 | |
| LLSGIVSIQRATPAR | 436 | Q13505 | |
| FRTSSVLRLTIIVGP | 476 | Q12805 | |
| LIRTRAVTQVLVPGL | 11 | P82914 | |
| VPLLRTGSRQVIIRV | 391 | Q86VV8 | |
| ISLFAVRLLQTLLPV | 476 | Q86VV8 | |
| TLARRVFLGEVIIPL | 401 | Q4VX76 | |
| RIITPRLALTTAEFL | 271 | P21281 | |
| RIPRVILTNVLGTEL | 161 | Q9BQF6 | |
| VSLILGLTPFVFRLS | 506 | Q8N3S3 | |
| RFLTLLLISPVLSRV | 341 | Q4G0N8 | |
| RFILPVAVTILGLRD | 416 | Q4G0N8 | |
| RPVTLIGFSLGARVI | 396 | Q5TGY1 | |
| IRQLATSGRFIVIIP | 871 | Q9UPR3 | |
| RGILESIQRFSLLPT | 31 | Q14C87 | |
| IVAPLLLRNTSARSV | 201 | Q9Y2G5 | |
| LRVLVLTGLQDVRFP | 156 | Q92546 | |
| RLLRPTLQFGLVAVS | 196 | O14494 | |
| QTSRIAIGPLRLSTL | 1326 | Q96Q15 | |
| SLLASLRTRAQLPVV | 556 | Q15477 | |
| VSPIVLRLNFSLVGT | 726 | P11215 | |
| RLLQFVTGSTRVPLQ | 676 | Q9HCE7 | |
| SGLPLLVQRTIARTI | 191 | P36897 | |
| ASIQPITRTVLRVTL | 1186 | Q8N3C0 | |
| LVLGFVLASRLVLPR | 16 | Q86X52 | |
| PVRSSLLGILLQVTR | 6 | Q6UE05 | |
| VSLGLSFRRPNVITL | 51 | Q5HYK9 | |
| TRLLFLQLVLGPTLV | 6 | Q5GAN3 | |
| PIPLRQTRFLSVTLV | 271 | Q70EL4 | |
| QRFLRVGLAVPILST | 291 | Q70EL4 | |
| LRTLPRSGNLIVVES | 276 | Q9H1C4 | |
| VLTQVINRFRTIPLT | 411 | Q9UBY0 | |
| VSLVVILPLSLFRNL | 201 | Q96QD8 | |
| VSPTLFRVIRLARIG | 1611 | Q9UQD0 | |
| RVGTLFRLLIEPVIF | 451 | Q9GZR1 | |
| SEFPNGRLTLLVTRL | 1611 | P08922 | |
| LRTGIPRQLLLQVES | 286 | Q8IUF8 | |
| SPLIRATVGILITTI | 111 | Q92973 | |
| VSGIQVLLTLLEPRR | 266 | Q9UPN7 | |
| QRLSLLSRTQVPLIT | 1056 | Q86YA3 | |
| LLAVPFVLTLRISVG | 161 | Q6UWM9 | |
| RVLIGNIDLSRLIFP | 481 | O43895 | |
| LRLIHIFTVSRNLGP | 841 | Q7Z2W7 | |
| AIGLSIIPARFTRVL | 231 | Q01831 | |
| VRSNPSVLQGLLRII | 4606 | Q5T4S7 | |
| RNLAIVFGPTLVRTS | 1296 | Q5T5U3 | |
| FSTRIQLTLIPITLG | 126 | Q7Z769 | |
| RFLSQVLGRVLQLLP | 276 | Q13488 | |
| PFRVLLVLTSHRGIQ | 81 | Q9H977 |